Related Experiment Videos
[A trichlormethiazide-amiloride combination in essential hypertension]
Deutsche Medizinische Wochenschrift (1946)
|March 8, 1985
Summary
This study found that a combination of trichlormethiazide and amiloride effectively reduced blood pressure in patients with essential hypertension. The treatment was well-tolerated, with minimal impact on serum electrolytes and other biochemical parameters.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Essential hypertension remains a significant global health concern.
- Effective and well-tolerated antihypertensive medications are crucial for managing blood pressure.
- Combination therapies are often employed to achieve better blood pressure control.
Purpose of the Study:
- To evaluate the efficacy and tolerability of a fixed-dose combination of trichlormethiazide and amiloride in patients with essential hypertension.
- To assess the impact of this combination therapy on blood pressure and serum electrolyte levels.
Main Methods:
- A 2-week placebo period was followed by 8 weeks of treatment with trichlormethiazide (2 mg) and amiloride (2 mg) in 39 patients.
- Dosage adjustments were made based on blood pressure response.
- Blood pressure, serum electrolytes, and other biochemical parameters were monitored throughout the study.
Main Results:
- Mean systolic blood pressure decreased from 167/163 mmHg to 151/148 mmHg (sitting/standing).
- Mean diastolic blood pressure decreased from 104/105 mmHg to 93/94 mmHg (sitting/standing).
- The treatment was generally well-tolerated, with stable serum potassium levels in most patients and no significant changes in other biochemical markers.
Conclusions:
- The combination of trichlormethiazide and amiloride is an effective antihypertensive treatment for essential hypertension.
- This combination therapy demonstrates good tolerability and a favorable safety profile regarding electrolyte balance and other biochemical parameters.